Talphera (TLPH) Price to Book (2011 - 2026)
Talphera (TLPH) posted Price to Book of 5.4 for Q2 2026, up 90.55% on a QoQ basis from 2.83 in Q1 2026, and up 125.3% year-over-year from 2.4 in Q2 2025.
Analysis
Talphera (TLPH) Price to Book (2011 - 2026) Analysis & Trends
Talphera has reported Price to Book for 16 years, with the latest figure at 5.4 in Q2 2026.
- On a quarterly basis, Price to Book rose 125.3% year-over-year to 5.4 in Q2 2026; TTM through Jun 2026 was 5.4, a 125.3% increase from a year earlier, with the FY2025 full-year figure at 3.3, up 96.52% from the prior year.
- Price to Book was 5.4 for Q2 2026 at Talphera, up from 2.83 in the prior quarter.
- The five-year high for Price to Book was 5.4 in Q2 2026, with the low at 1.11 in Q1 2022.
- Average Price to Book over 5 years is 1.71, with a median of 1.62 recorded in 2024.
- The sharpest annual moves came in 2023 and 2024: Price to Book sank 52.99% in 2023, then jumped 335.36% in 2024.
- Over 5 years, Price to Book stood at 0.85 in 2022, then advanced by 4.13% to 0.89 in 2023, then jumped by 88.87% to 1.68 in 2024, then jumped by 96.52% to 3.3 in 2025, then soared by 63.58% to 5.4 in 2026.
- The last three Price to Book figures came in at 5.4 (Q2 2026), 2.83 (Q1 2026), and 3.3 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Talphera | 92.90 Mn | 92.90 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.40 |
| Mar 31, 2026 | 2.83 |
| Dec 31, 2025 | 3.30 |
| Sep 30, 2025 | 2.12 |
| Jun 30, 2025 | 2.40 |
| Mar 31, 2025 | 2.35 |
| Dec 31, 2024 | 1.68 |
| Sep 30, 2024 | 2.34 |
| Jun 30, 2024 | 1.83 |
| Mar 31, 2024 | 1.56 |
| Dec 31, 2023 | 0.89 |
| Sep 30, 2023 | 0.54 |
| Jun 30, 2023 | 1.17 |
| Mar 31, 2023 | 0.51 |
| Dec 31, 2022 | 0.85 |
| Sep 30, 2022 | 1.14 |
| Jun 30, 2022 | 1.07 |
| Mar 31, 2022 | -1.11 |
| Dec 31, 2021 | -2.13 |
| Sep 30, 2021 | -2.83 |